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Margins of wide local excisions in breast conserving surgery are tested through histology, which can 
delay results by days and lead to second operations. Detection of margin involvement intraoperatively 
would allow the removal of additional tissue during the same intervention. X‑ray phase contrast 
imaging (XPCI) provides soft tissue sensitivity superior to conventional X‑rays: we propose its use to 
detect margin involvement intraoperatively. We have developed a system that can perform phase‑
based computed tomography (CT) scans in minutes, used it to image 101 specimens approximately 
half of which contained neoplastic lesions, and compared results against those of a commercial 
system. Histological analysis was carried out on all specimens and used as the gold standard. XPCI‑CT 
showed higher sensitivity (83%, 95% CI 69–92%) than conventional specimen imaging (32%, 95% CI 
20–49%) for detection of lesions at margin, and comparable specificity (83%, 95% CI 70–92% vs 86%, 
95% CI 73–93%). Within the limits of this study, in particular that specimens obtained from surplus 
tissue typically contain small lesions which makes detection more difficult for both methods, we 
believe it likely that the observed increase in sensitivity will lead to a comparable reduction in the 
number of re‑operations.
Breast-conserving surgery (BCS) followed by adjuvant therapy is the preferred standard of care for early-stage 
breast  cancer1. The success of BCS depends on the removal of the entire neoplastic lesion, which is determined 
through histopathological analysis of the margins of the resected wide local excision (WLE). This is usually 
only available after several days, when any detected margin involvement must be discussed with the patient and 
re-operation considered. Re-operations cause patient stress, worse cosmetic outcomes and additional costs to 
healthcare systems. Their incidence varies among centres, with a recent study showing it can be as high as 41% 
with a median of 17.2%2.
A mechanism to detect margin involvement intraoperatively would allow for the removal of additional tis-
sue during the same intervention thus avoiding re-operations. Most practice (e.g. in the UK) involves the use 
of planar X-ray  radiography3, which is affected by the known limitations of X-rays in detecting faint soft-tissue 
 changes4, such as those entailed by low-grade ductal carcinoma in situ (DCIS), invasive lobular carcinoma and 
microscopic margin involvement and tumour strands in general. Other approaches currently in use include 
intraoperative ultrasonography, which also suffers from similarity in tissue density, and pathology assessment 
with frozen sections or touch imprint cytology, which are time consuming, require on-site laboratory facilities, 
and in the latter case only allow localised assessments.
This lack of a satisfactory solution has generated research effort into alternative methods. These include 
approaches based on optical/infra-red wavelengths such as Raman  spectroscopy5, Optical Coherence 
 Tomography6 and optical sectioning microscopy  methods7,8, or on  radiofrequency9; these typically probe 
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specimens only at specific locations, and suffer from limited penetration depth. More recent methods involve 
administering radionuclides to allow the detection of Cherenkov  radiation10, which exposes patients and prac-
titioners to radiation, and diathermy smoke detection by mass spectrometry coupled to a surgical  scalpel11. This 
shows promise, however it cannot detect close (as opposed to involved) margins, and requires characterisation 
of molecular signatures for all possible at-risk lesions.
X-ray micro-CT fulfils key requirements of tissue penetration, spatial resolution, simultaneous analysis of the 
entire specimen in a sufficiently short timeframe, and it has indeed been proposed for intraoperative  use12, the 
main obstacle being the limited soft tissue sensitivity of conventional X-ray  imaging4. This can be overcome by 
X-ray phase contrast imaging (XPCI), the efficacy of which in the detection of breast tumours has been repeatedly 
 proven13–16, including in vivo17. This study aims to demonstrate the feasibility and the prospective advantages of 
using XPCI for intraoperative imaging of WLEs. It should be noted that, since we are comparing our approach 
to conventional specimen radiology, the enhancements we demonstrate in this paper arise from two factors: 3D 
visualisation of the specimen, which was already proven to bring some  advantages18–21, and increased soft-tissue 
sensitivity arising from XPCI, also proven advantageous by previous  studies13–17. We focused on the comparison 
with conventional specimen radiology because it is one of the most commonly used tools in breast conserving 
surgery; comparisons with more advanced modalities will be the subject of future studies.
Results
We scanned 101 WLE-like specimens obtained from tissue surplus to central diagnosis with our breadboard 
XPCI-CT system (see “Methods” section); 99 of these were also scanned with a conventional specimen imaging 
system. Following phase retrieval and CT reconstruction (see “Methods” section), the team’s radiologist scored 
all XPCI-CT images for tumour presence; when detected, it was determined whether the lesion reached the 
specimen’s margins. The same analysis was applied independently to the images obtained with the commercial 
specimen radiology system. Once the “ground truth” was obtained through histopathology assessment, data were 
aggregated in the 2 × 2 contingency tables reported below. For all three modalities a lesion distance < 1 mm from 
the margin was considered as a “positive” margin, in keeping with clinical practice.
Table 1 shows the XPCI-CT results for detection of tumour at margin. Sensitivity and specificity values are 
83% (95% CI 69–92%) and 83% (95% CI 70–92%), respectively. Table 2 shows the same results for conventional 
specimen imaging. Sensitivity and specificity are 32% (95% CI 20–49%) and 86% (95% CI 73–93%), respectively. 
These results confirm that the main objective of the study has been achieved, namely a statistically significant 
improvement in sensitivity by XPCI-CT for the detection of involved margins.
Cases where “tumour at margin” was classed as “unsure” by the radiologist were assigned to the yes category; 
tables in which uncertain cases were excluded from the analysis are reported in the supplementary information 
(ST1 and ST2), and show no significant differences in sensitivity and specificity. Tables reporting the detection 
of tumour regardless of its position in the specimen are also reported for completeness in the supplementary 
information (ST3 and ST4), again showing no significant differences in the sensitivity and specificity values.
XPCI-CT slices showed a wealth of details invisible in conventional specimen radiography, thanks to the 
increased sensitivity provided by phase effects combined with the system’s spatial resolution of approximately 
100 mm22.
Visual comparison between XPCI-CT and histopathological slices reveals a strong similarity between the 
two. Most details are visible in both modalities, leading to an ease of correlation between corresponding features. 
Crucially, this includes features that are the main target of this study, including thin tumour strands extending 
all the way to the margin of the specimen, faint DCIS, small calcifications. Typical examples are reported in 
Fig. 1, which demonstrates XPCI-CT’s ability to detect faint tumour margins, inhomogeneity inside tumour 
masses, tumour-induced inflammation and small calcifications in DCIS, all confirmed by histopathology. Similar 
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matches were repeatedly seen across all specimens for which histology and XPCI-CT were compared visually. 
Many other tumour-related features become visible, not limited to margin assessment. These provide additional 
information such as multi-focality, variations in tumour structure, 3D pattern of calcifications, necrosis and 
tumour-induced inflammation.
The 3D visualisation means that tumour strands can be identified near the main tumour site where they are 
thicker, and followed through the volume as they become thinner until they reach the specimen’s margins. This 
can be done flexibly, e.g. either by following features while scrolling through adjacent slides, through maximum 
intensity projections or by using 3D rendering representations of the sample, examples of which are provided in 
Fig. 2. As well as highlighting the improved visualisation of expanded ducts, Fig. 2 provides an additional example 
of margin invasion by a metaplastic (matrix-producing) carcinoma, again supported by histology confirmation.
Feasibility of clinical translation. At the end of the study, encouraged by the positive results, we con-
ducted an investigation into the clinical viability of the proposed technology, in terms of providing a sufficiently 
large field of view (FoV) and acquisition times sufficiently short for intraoperative use. The first step was to con-
duct a survey of the average size of 248 WLEs which arrived consecutively at the breast tissue bank of Barts hos-
pital in London (see Fig. 3). This confirmed that a FoV of 9 cm would be sufficient to cover over 90% of the cases.
Based on this knowledge, we designed new pre-sample and detector masks analogous to those described in 
the materials and methods section below, but with overall areas equal to 9 × 9 cm2 and 11.5 × 11.5 cm2, respec-
tively. Masks were then incorporated into a cabinet-based pre-commercial prototype featuring the same X-ray 
source and detector as the breadboard system; however, a modification in the detector firmware was requested 
to the manufacturer (Hamamatsu), in order to enable shorter (0.4 s) acquisition times for the individual frames, 
thus allowing faster CT acquisitions. The system was tested on a larger (approx. 5 cm diameter), fresh WLE 
Figure 1.  Examples of the imaging performance of XPCI-CT (b,e) compared to conventional specimen 
radiography (a,d) and benchmarked against histopathology (c,f). The top row focuses on the similarity between 
the XPCI-CT slice in (b) and the histological slice in (c). Arrow 1 indicates margin involvement, arrow 2 a 
variation in density in the internal structure of the tumour mass, arrow 3 tumour-induced inflammation. All 
this is confirmed by the histological slice in (c), and hardly visible in the conventional image in (a). The bottom 
row focuses on the detection of small calcifications, a key feature in DCIS. These are undetectable in (d), 
detected in (e), enhanced in the maximum intensity projection (MIP) image at the bottom of (f), and confirmed 
by histopathology in the top part of (f). The scale bar [shown in (b) and (e)] is the same for all images apart from 
(f), which has its own scale. Red arrows in (e) and (f) indicate the microcalcifications.
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specimen resected immediately before the scan, with results for two different acquisition times (15 and 10 min) 
shown in Fig. 4.
Albeit a grainier texture, resulting from the combination of faster scans and thicker samples, becomes appar-
ent in the zoomed-up regions of interest, all key image features remain visible, despite the larger specimen 
size and scan times being reduced to a level compatible with intraoperative use. Notably, image quality is only 
marginally affected when the scan time is reduced from 15 to 10 min, indicating the possibility for additional 
reductions, which will be explored in a dedicated study. Image reconstruction took an additional 10–15 min (on 
a 24-core PC), however this was not optimised yet at this stage.
Figure 2.  Versatility of representation offered by the XPCI-CT approach. The top row focuses on calcified 
DCIS, also detectable in the conventional image (a). However, the clear delineation of the enlarged ducts in 
the XPCI slice (b) should be noted (red arrows), which can be followed along their length through successive 
slices. Alternatively, MIPs can be used (c), or more sophisticated 3D rendering approaches such as solid casting 
followed by segmentation (e.g. fat tissue was segmented out in panel d, allowing the visualisation of an entire 
blood vessel and calcifications therein, blue arrow). The bottom row shows an involved margin, less clearly 
visible in the conventional image (e) and highlighted by an arrow in the XPCI slice (f), where the inset shows 
confirmation by histopathology, and in the MIP in (g). The 3D rendering in (h) allows visualising edge of the 
tumour (a metaplastic carcinoma), characterised by diffuse invasion along fibrous strands.
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Discussion
This study was aimed at demonstrating the feasibility and prospective advantages of using XPCI for intraopera-
tive imaging of WLEs.
Demonstration of prospective advantages was addressed by analysing 101 WLE-like specimens obtained 
from surplus tissue. These specimens had two key differences with respect to real WLEs: tumour presence was 
uncertain (and unknown to the investigators until after the results of histological workup were disclosed to the 
team) and, where tumour was present, this could be small in size since the main lesion had already been removed 
from the original specimen for diagnostic purposes. This is likely to have made lesions more difficult to detect 
than in real WLEs, which could explain the limited sensitivity performance of the conventional specimen imag-
ing system. In addition, in normal clinical practice the radiologist would also use information available from the 
pre-operative imaging, which is not available in this case. However, sensitivities as low as 20% have been reported 
in the literature for standard specimen  mammography23, with other studies reporting only marginally higher 
sensitivity values for certain  cancers24. Smaller and fainter lesions would be harder to detect for both methods, 
and our study focused on their relative comparison.
We found comparable specificity, but a significantly enhanced sensitivity for XPCI-CT. A significantly 
increased sensitivity was the main target of our study, as it is key to achieve a more efficient detection of margin 
involvement, and therefore a reduction of the reoperation rate. The high similarity between XPCI-CT and histo-
logical slices, and the wealth of additional details which can be detected and identified compared to conventional 
specimen imaging, provides a further, strong indication of the prospective usefulness of XPCI-CT becoming 
available intraoperatively.
To demonstrate feasibility and compatibility with clinical requirements, we developed a pre-commercial pro-
totype based on the breadboard system design, but with larger masks and modified detector firmware to deliver 
faster frame rates. This enabled reaching a FoV of 9 × 9  cm2, which we demonstrated would be sufficient to cover 
over 90% of the cases encountered in clinical practice by analysing the size distribution of 248 consecutive WLEs 
collected at our reference hospital. The pre-commercial prototype also enabled demonstrating an overall scan 
time of 10 min, the further reduction of which will be investigated in a future study, including across a range of 
WLE sizes and types of malignancy. In particular, it would be important to provide a breakdown of sensitivity 
and specificity versus lesion type, for which at the current stage we felt we did not have a sufficient statistic for 
each case to support statistically significant conclusions.
In summary, the obtained gain in sensitivity shows that clinical introduction of the technology would be 
beneficial and translate into a comparable reduction in re-operations; the demonstration that this can be attained 
with a compact system featuring a FoV sufficient to cover over 90% of WLEs at scan times compatible with 
intraoperative use proves it is viable. It would also be the only fully 3D method available for intra-operative 
specimen imaging, with a resolution of the order of 100 μm over the entire  volume22, and soft tissue sensitivity 
Figure 4.  XPCI-CT slices of a 5 cm diameter WLE specimen acquired with an overall scan time of 15 min (a) 
and 10 min (b). Zoomed-up regions of interest show images on the same scale as Figs. 1 and 2.
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sufficient to detect faint tumour features. It would allow the operator to follow tumour strands from the main 
mass where they are thicker and easily recognisable, and determine whether they reach the specimen margin.
Once introduced, the technology could provide additional advantages. As well as CT scans in minutes, the 
XPCI machine can provide planar (projection) images in seconds. Alongside “single shot”25,26 images enhanc-
ing visibility of tumour features, “multi-modal” 2D images can be obtained, in which the contributions of X-ray 
attenuation, phase and potentially scatter are separated out, highlighting different features of the specimen (see 
Fig. S1 in the supplementary information and related discussion). This lends itself to a “hybrid” use where the 
surgeon or radiologist could rapidly examine the WLE in 2D from different orientations, and launch a full CT 
scan only when the 2D images are insufficient to confidently determine whether margin involvement is pre-
sent. The ability to detect metastatic tumour in sentinel lymph nodes also could be explored, providing further 
potential to reduce second operations due to unexpected positive nodes. Applications can be envisaged beyond 
breast, to other areas where a 3D method with high soft tissue sensitivity would be beneficial (e.g. intestinal, 
oesophageal or prostatic surgery). The machine could be used to aid slide selection in pathology, especially for 
multi-focal lesions, or simply by providing a three-dimensional “digital histology” support. It would also help 
accelerating the clinical uptake of XPCI, alongside pilots such as the mammography study with synchrotron 
radiation in Trieste,  Italy17 and the lung study underway in Munich,  Germany27.
Our study’s limitations arise from its still preliminary nature, dictated by the need to demonstrate its potential 
without disrupting the clinical workflow, which imposed the use of surplus tissue. Additional limitations may 
come from image assessment being conducted by a single multi-disciplinary medical team, which however rep-
resents the situation encountered in clinical practice for BCS. Future work needs to include teams from a variety 
of hospitals. Finally, it must be noted that, despite the enhanced sensitivity, XPCI-CT still misses some cancers 
ultimately detected by histopathology, hence further improvements should be pursued. It became clear during 
the study that additional training should be provided to the radiologist; however, encouraging indications were 
provided by the reasonably high levels of specificity that could be achieved also with minimal training, which 
we expect leaves room for further improvement.
Our key result is a > 50% increase in sensitivity over conventional specimen radiology (from 32 to 83%). 
Although the performance of the conventional system is likely to have been affected by the use of WLE-like 
specimens created using surplus tissue, which resulted in smaller and fainter lesions compared to real WLEs, 
this would have comparably affected the performance of XPCI-CT. Within the limits of the present preliminary 
study, this result indicates that introduction of XPCI-CT as an intra-operative specimen imaging tool could 
lead to a reduction in repeat operations by a rate comparable to the observed increase in sensitivity over the 
conventional method.
Methods
X‑ray phase contrast CT. XPCI exploits the changes in speed with which X-rays travel through different 
tissues, a stronger effect than the variations in X-ray attenuation caused by the same  tissues28. This was proven to 
enhance soft tissue contrast, including of breast  tumours13–17. Several methods have been developed to translate 
phase effects into image  contrast13–17,28–36; importantly, implementations with conventional X-ray sources are 
now  possible31,32, including in  CT33–36. Early CT implementations required multiple images at each projection 
angle to “disentangle” phase from attenuation effects (phase retrieval). This prevented a continuous rotation of 
the specimen, leading to acquisition times too long for intraoperative use. We developed an  adaptation26 of a 
“single-shot”  approach25 in which a pre-sample mask is kept stationary throughout the scan, and the object is 
continuously rotated. “Single shot”  approaches25,26 enable phase retrieval only for specimens which are fairly 
homogeneous in composition, which works well for BCS since WLEs are mainly soft tissue.
This study used a custom-built bread-board  scanner22,36, 70 cm long with a 15 cm sample-to-detector distance. 
A schematic is provided in Fig. 5, alongside a photo of the setup. It features a rotating anode Molybdenum source 
(Rigaku 007-HF Micro Max, Rigaku, Japan) operated at 40 kVp and 20 mA, a CMOS-based flat panel detector 
(C9732DK-11, Hamamatsu, Japan) with 50 μm pixel size. The key difference over a conventional micro-CT 
Figure 5.  The breadboard XPCI-CT system. (a) A photograph of the system, with flat panel detector, the two 
masks in aluminium frames and the X-ray source (on a separate table) recognisable from left to right. (b) A 
schematic of the system (seen from above, not to scale), showing how mask M1 splits the beam into multiple 
beamlets before the sample, and how these hit the edges of an aperture on the detector mask M2. The way in 
which small deviations of the beamlets lead to a change of detected intensity in some pixels is also schematized.
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system is the introduction of two masks featuring long, regularly spaced vertical apertures. One mask (area 5.5 
(H) × 2.0 (V) cm2, aperture size 12 μm, aperture period 38 μm) is placed immediately before the specimen, the 
other (area 6.0 (H) × 2.5 (V) cm2, aperture size 20 μm, aperture period 48 μm) in front of the detector. A lateral 
displacement between the masks enhances the signal created by X-rays that deviated from their original direction, 
i.e. the phase contrast (see Fig. 5b); for this system, a 9 μm displacement results in maximum phase  sensitivity22. 
Both masks were fabricated to the authors’ design by Microworks GmbH (Karlsruhe, Germany) by electroplat-
ing an approximately 120 μm thick gold layer on a patterned 400 μm thick graphite substrate. 2500 projections 
were collected while the specimen was rotated continuously over 360 degrees at a speed of 0.1 °/s. This 1 h scan 
duration was reduced to 10 min in an optimised pre-commercial prototype employing a higher X-ray flux and 
a detector with a faster frame rate (see “Feasibility of clinical translation” section). This pre-commercial system 
also employed much larger masks (9 × 9 cm2 and 11.5 × 11.5 cm2 for sample and detector mask respectively, both 
still fabricated by Microworks GmbH), to allow scanning larger specimens.
Specimen preparation, conventional radiography and histopathology. 101 WLE-like specimens 
were obtained from tissue surplus to central diagnosis, to avoid disruptions to the clinical workflow. All samples 
were obtained from patients who consented for use of their tissue in research as part of the Barts Cancer Institute 
Breast Tissue Bank (Ref:15/EE/0192). For ease of transportation, storage and scanning, all specimens were fixed 
in 10% formal saline for at least 24 h. To ensure this would not affect the results of our study, the same specimen 
was scanned before and after fixation, and no significant difference was observed in the resulting images by the 
team’s radiologist, or in the extracted quantitative contrast values (see supplementary information, Fig. S2 and 
Table ST5).
All specimens underwent XPCI-CT; 99 were also imaged post-fixation with the hospital’s specimen radi-
ography system (Bioptics Core Vision, Bioptics Inc, Tucson, USA), to allow a direct comparison with current 
practice. Following imaging with both systems, histological examination was carried out on all specimens. The 
entire WLE-like sample was blocked out for analysis, taking full-face slices into conventional or megablock 
cassettes. These underwent routine processing and embedding in paraffin wax. A 4 μm section was taken from 
each block and stained with haematoxylin and eosin according to standard protocols. In selected cases, deeper 
levels were taken through the block to ensure full representation of the lesion.
Image reading and statistical analysis. The team’s radiologist blindly assessed all images and assigned 
them to one of three categories: cancer present, cancer at margin or no cancer. While conventional images 
posed no issue due to their familiar appearance, XPCI-CT images required some degree of training, since their 
enhanced sensitivity meant many more details became visible compared to what is normally observed in clinical 
practice (see Fig. 1 as an example). Without training, these additional features could be interpreted as lesions, 
thus distorting the specificity assessment. 10 datasets, excluded from successive analysis, were used for training 
purposes by unblinding the pathology’s results to the radiologist. This allowed their correct interpretation, and 
after repeating this process over 10 samples the radiologist felt more confident in routinely interpreting these 
features. Multi-planar reformation (MPR) in three planes was used in the assessment of the XPCI-CT images.
Histopathological analysis classified each tissue sample as belonging to one of the three above categories, 
and was used as the “gold standard” against which both XPCI-CT and conventional specimen imaging were 
compared. The tissue samples were orientated with inks prior to imaging, to allow images and histology to be 
viewed in the same orientation. The entire specimen was embedded, superior to inferior. Any lesion identified 
on imaging was located as a distance from superior aspect of the specimen, enabling the histology blocks to be 
levelled through to the correct distance. In all cases, a histological correlate of the lesion on imaging was identi-
fied. The other team members were kept blind to this classification.
2 × 2 contingency tables were created for image readings resulting from both conventional and XPCI-CT 
imaging (based on 99 and 101 specimen, respectively), to establish their sensitivity and specificity against tumour 
presence at margins through comparison against the histopathology gold standard. Where the presence of tumour 
at margins was classified as “uncertain” by the radiologist, this was counted as a “yes” in the contingency tables, 
based on the assumption that this would lead to the resection of additional tissue in a BCS procedure. Alternative 
tables excluding all uncertain calls are provided in the supplementary information. 95% Confidence Intervals 
(CIs) were obtained assuming the numbers correctly classified had a binomial  distribution37.
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